Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

UNC researchers reveal genetic underpinnings of Foxp3-expressing regulatory T cells

Within the immune system, a subtle balance exists between the cells that destroy alien pathogens and those that preserve the body's own tissues. When the balance gets out of whack, the cells that normally target viruses or bacteria can go astray, attacking innocent cells and causing autoimmune and inflammatory disease.

20 Sep 2011

Aestus to develop ATx09-002 for treatment of neuropathic pain

Aestus Therapeutics, Inc. and Prosidion Ltd., a wholly owned subsidiary of Astellas Pharma Inc., announced today a license agreement providing Aestus with exclusive, world-wide rights to the Prosidion investigational product PSN-357.

19 Sep 2011

NTNU genetic research shows best recipe to limit risk of lifestyle-related diseases

What should we eat? Answers abound in the international media, all of which rely on their interpretation of recent medical literature to come up with recommendations for the healthiest diet. But what if you could answer this question at a molecular level - what if you could find out how our genes respond to the foods we eat, and what this does to the cellular processes that make us healthy - or not? That's precisely what biologists at the Norwegian University of Science and Technology have done.

19 Sep 2011

Two newer Type 2 diabetes drugs could be linked to increased risk of pancreatic cancer

Two newer drugs used to treat Type 2 diabetes could be linked to a significantly increased risk of developing pancreatitis and pancreatic cancer, and one could also be linked to an increased risk of thyroid cancer, according to a new UCLA study.

19 Sep 2011

Novel therapies remove the brakes cancer puts on the immune system

Some of the newest therapies in the war on cancer remove the brakes cancer puts on the immune system, Georgia Health Sciences University researchers report.

17 Sep 2011

Multiple abstracts on QNEXA presented at 47th EASD

VIVUS, Inc. today announced that multiple abstracts were presented at the 47th European Association for the Study of Diabetes (EASD) Annual Meeting in Lisbon, Portugal. The presentations highlighted the long-term beneficial effects of QNEXA treatment in metabolically-impaired patients with prediabetes, diabetes, and metabolic syndrome.

17 Sep 2011

DARA's KRN5500 meets primary end-points in Phase II study for chemotherapy-induced neuropathic pain

Thanks to greater awareness, earlier detection and improving therapeutic agents, people with cancer are living longer than ever before. One of the consequences of living longer is the symptom burden of cancer survivorship, which may have a substantial impact on quality of life for many survivors. One such burden is the pain syndromes resulting from cancer treatments.

17 Sep 2011

New diabetes drugs linked to increased risk of pancreatitis and pancreatic cancer

17 Sep 2011

Harvard’s own ‘Healthy Eating Plate’ as an improvement upon USDA’s MyPlate

A few months earlier the United States Department of Agriculture unveiled ‘MyPlate’, the replacement for the food pyramid. Now the Harvard School of Public Health says that MyPlate doesn't offer enough about good nutrition, and they have offered their own version.

16 Sep 2011

ONGLYZA used with insulin maintains improvement in glucose control in adults with type 2 diabetes

Bristol-Myers Squibb Company and AstraZeneca today announced results from an investigational Phase 3b clinical study in which the addition of ONGLYZA (saxagliptin) 5 mg to ongoing insulin therapy (with or without metformin) maintained reductions of blood sugar levels (glycosylated hemoglobin levels, or HbA1c) in adult patients with type 2 diabetes compared to the addition of placebo (with or without metformin) from 24 to 52 weeks.

16 Sep 2011

Linagliptin demonstrates durable reductions in blood glucose for T2D adults

Boehringer Ingelheim and Eli Lilly and Company today announced results of a 102 week Phase III study for linagliptin, which show meaningful and durable reductions in blood glucose for adults with type 2 diabetes.

16 Sep 2011

Lack of communication between diabetes patients and physicians around hypoglycaemia: Survey

New multinational survey data released to coincide with the European Association for the Study of Diabetes (EASD) 47th Annual Meeting has revealed a lack of communication between type 2 diabetes patients and physicians around hypoglycaemia.

15 Sep 2011

Novo Nordisk's insulin degludec reduces blood sugar in patients with type 2 diabetes

Ultra-long-acting insulin degludec, an investigational basal insulin being developed by Novo Nordisk, showed significant blood sugar reductions in patients with type 2 diabetes.

From Novo Nordisk 15 Sep 2011

Uterine stem cells could help treat diabetes

Controlling diabetes may someday involve mining stem cells from the lining of the uterus, Yale School of Medicine researchers report in a new study published in the journal Molecular Therapy.

15 Sep 2011

SARcode Bioscience initiates enrollment in SAR 1118 Phase 3 study for dry eye disease

SARcode Bioscience, Inc., a privately-held biopharmaceutical company, announced today that the initial patient has been enrolled in the company's pivotal Phase 3 clinical study (OPUS-1) of SAR 1118 ophthalmic solution.

15 Sep 2011

Enrollment commences in ConjuChem's CJC-1134-PC Phase 2 trial for Type 2 diabetes

ConjuChem, LLC, a biotechnology company dedicated to the discovery of novel therapeutics, today announced it has initiated patient enrollment for its Phase 2 clinical trial of its proprietary GLP-1 receptor agonist drug, CJC-1134-PC, in patients with Type 2 diabetes mellitus who are receiving metformin monotherapy.

15 Sep 2011

Teen milk drinkers less likely to suffer from Type 2 diabetes

Developing healthy habits like drinking milk as a teen could have a long-term effect on a woman's risk for type 2 diabetes, according to new research in this month's issue of the American Journal of Clinical Nutrition.

14 Sep 2011

A woman's pregnancy outcome can be an indicator of future health conditions

"A woman's pregnancy outcome can be an indicator of future health conditions," stated George R. Saade, M.D., president of the Society for Maternal-Fetal Medicine and professor of obstetrics and gynecology at The University of Texas Medical Branch in Galveston, Texas.

14 Sep 2011

IDF, Albert Einstein College of Medicine to host Global Diabetes Symposium

While infectious diseases tend to grab media headlines and public attention, non-communicable diseases such as diabetes, cancer, cardiovascular disease, and chronic respiratory diseases together comprise the number one killer in the world and represent a serious social and economic burden to developed and developing countries alike.

14 Sep 2011

Diabetes epidemic grips the world

Experts are horrified with the rise of numbers of diabetics worldwide. A staggering 366 million people around the world have either Type 1 or 2 diabetes, says the International Diabetes Federation. The disease has taken a deadly toll, causing 4.6 million deaths each year, or one death every seven seconds. The number of sufferers was pegged at 285 million worldwide in 2009. Since then, China reported 92.4 million people with the condition, more than double the federation’s estimate. The diabetes epidemic is also heavy on healthcare spending, to the tune of $465 billion a year to fight the disease.

14 Sep 2011

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

UNC researchers reveal genetic underpinnings of Foxp3-expressing regulatory T cells

Aestus to develop ATx09-002 for treatment of neuropathic pain

NTNU genetic research shows best recipe to limit risk of lifestyle-related diseases

Two newer Type 2 diabetes drugs could be linked to increased risk of pancreatic cancer

Novel therapies remove the brakes cancer puts on the immune system

Multiple abstracts on QNEXA presented at 47th EASD

DARA's KRN5500 meets primary end-points in Phase II study for chemotherapy-induced neuropathic pain

New diabetes drugs linked to increased risk of pancreatitis and pancreatic cancer

Harvard’s own ‘Healthy Eating Plate’ as an improvement upon USDA’s MyPlate

ONGLYZA used with insulin maintains improvement in glucose control in adults with type 2 diabetes

Linagliptin demonstrates durable reductions in blood glucose for T2D adults

Lack of communication between diabetes patients and physicians around hypoglycaemia: Survey

Novo Nordisk's insulin degludec reduces blood sugar in patients with type 2 diabetes

Uterine stem cells could help treat diabetes

SARcode Bioscience initiates enrollment in SAR 1118 Phase 3 study for dry eye disease

Enrollment commences in ConjuChem's CJC-1134-PC Phase 2 trial for Type 2 diabetes

Teen milk drinkers less likely to suffer from Type 2 diabetes

A woman's pregnancy outcome can be an indicator of future health conditions

IDF, Albert Einstein College of Medicine to host Global Diabetes Symposium

Diabetes epidemic grips the world

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in